Conversely, though there are abundant androgen receptors in normal breast tissue and androgen receptors are also frequently expressed in breast cancers, there is no evidence for increased breast cancer incidence in women with hyperandrogenism such as polycystic ovary syndrome, or in transgender men receiving testosterone treatment [21]. This evidence concerns the gene AR and polycystic ovary syndrome.